Loading insider details...
Beta
Latest Form 4 (Jun 14, 2024): Exercise/Conversion of 105,263 DNA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 14, 2024 | Ginkgo Bioworks Holdings, Inc. (DNA) | Exercise/Conversion | 105,263 | n/a |
| Jun 7, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 10,461 | n/a |
| May 20, 2024 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale | 265,000 | $220.0K |
| May 14, 2024 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale | 1,727,056 | $1.61M |
| Jun 21, 2023 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/Award | 105,263 | n/a |
| May 13, 2022 | Quantum-Si Inc (QSI) | Grant/Award | 59,880 | n/a |
| Jun 14, 2021 | Quantum-Si Inc (QSI) | Grant/Award | 500,000 | $5.00M |
| Jun 8, 2021 | Quanterix Corp (QTRX) | Exercise/Conversion | 1,951 | $15.9K |
| Jan 13, 2021 | Quanterix Corp (QTRX) | Exercise/Conversion | 7,900 | $144.1K |
| Jan 5, 2021 | Quanterix Corp (QTRX) | Grant/Award | 2,270 | n/a |